ARCHIVES

Zaltrap Price Cut In Half Effective Immediately

This article is from The Cancer Letter archive.

Vol. 38 No. 42 | November 8, 2012

Download PDF Visit The Full Archive

Related Articles

June issue of Business & Regulatory Report included.

July 2, 2004

Amgen Says ESA Use Dropped By Half In Fourth Quarter.

January 25, 2008

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

DCE Advisors OK Recompetitions Worth $10 Mil.

July 19, 1991

ASSIST Gets Extra Year Of Funding While NCI Considers Role In Tobacco Control

January 17, 1997

FDA’s Kweder cites Society of Professional Journalists’ Code of Ethics–incorrectly, SPJ says.

March 4, 2005